Clinical Trial Update: The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update evaluates mavacamten for hypertrophic cardiomyopathy with mid-to-apical left ventricular obstruction. The study status is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• CAMZYOS (MAVACAMTEN)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Hypertrophic Cardiomyopathy (HCM) | Phase 4 | Status: NOT_YET_RECRUITING